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Abstract The renin–angiotensin–aldosterone system (RAAS)
is not the sole, but perhaps the most important volume regula-
tor in vertebrates. To gain insights into the function and evo-
lution of its components, we conducted a phylogenetic analysis
of its main related genes. We found that important parts of the
system began to appear with primitive chordates and tunicates
and that all major components were present at the divergence
of bony fish, with the exception of the Mas receptor. The Mas
receptor first appears after the bony-fish/tetrapod divergence.
This phase of evolutionary innovation happened about 400
million years ago. We found solid evidence that angiotensino-
gen made its appearance in cartilage fish. The presence of
several RAAS genes in organisms that lack all the components
shows that these genes have had other ancestral functions
outside of their current role. Our analysis underscores the
utility of sequence comparisons in the study of evolu-
tion. Such analyses may provide new hypotheses as to
how and why in today's population an increased activity
of the RAAS frequently leads to faulty salt and volume
regulation, hypertension, and cardiovascular diseases,
opening up new and clinically important research areas
for evolutionary medicine.
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Introduction
Multicellular organisms regulate their internal environment
by either modifying the extracellular volume or the solute
concentration (osmolality). In mammals, the kidney is the
final common pathway for both of these functions. Low-
and high-pressure baroreceptors in various circulatory beds,
as well as ion channels and sensors in the distal tubule, infer
the body's volume. Ion channels in the hypothalamus sense
the sodium concentration and extracellular fluid osmolality.
Glomerular filtration rate, physical forces along the nephron,
the sympathetic nervous system, and the renin–angiotensin–
aldosterone system (RAAS) are the volume effectors. Osmo-
lality effectors include thirst stimulation, release of the anti-
diuretic hormone vasopressin, and the placement of aquaporin
water channels in the renal collecting duct so that concentrated
urine can be made. This study focuses on volume regulation.
The RAAS is the principal volume-regulatory effector in
mammals. It is a major regulator of blood pressure within
the human body. Therefore, the RAAS has important impli-
cations for study of hypertension and other cardiovascular
diseases [1].
The key effector precursor molecule of the RAAS is
angiotensinogen, a protein produced principally in liver
(Fig. 1a). Angiotensinogen is cleaved to a 10 amino-acid
peptide, angiotensin (Ang I), by a unique aspartyl protease
called renin, which is produced by the juxtaglomerular
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apparatus (JGA) in the kidney [2, 3]. The angiotensin-
converting enzyme (ACE) in turn cleaves Ang I to a smaller,
highly active 8 amino-acid peptide, angiotensin II (Ang II).
ACE is a matrix metalloproteinase that is particularly highly
concentrated on pulmonary endothelial cells, despite the fact
that numerous functions of the enzyme in other bodily tissues
besides the vasculature have been uncovered by elegant studies
using genetically modified mice [4]. Moreover, other enzymes
exhibit ACE-like activity, like the chymase, a protein mainly
found in mast cells, which mostly displays such an activity in
the heart [5]. Ang II acts on the adrenal cortex to release
aldosterone (ALD). ALD acts in the kidney, primarily on
collecting duct cells to effect reabsorption of sodium (and
chloride). Ang II also has its own independent sodium reab-
sorptive effects in the kidney, acts in brain to stimulate thirst
and salt appetite, as well as to increase sympathetic tone, and
acts directly on the vessel wall (primarily arterioles) to affect
vasoconstriction and to increase blood pressure [6]. Renin is the
rate-limiting step in Ang II production. Renin release is stimu-
lated by baroreflex mechanisms in the JGA, by beta-adrenergic
sympathetic innervation of these cells, and by solute delivery,
notably chloride content in the tubular fluid at the macula densa
segment of the distal tubule. A negative feedback loop inhibits
renin release that includes Ang II levels, inactivated baroreflex
sensors, and sympathetic inhibition.
The RAAS involves a series of proteins working in a net-
work (Fig. 1b). Renin, and its precursor molecule prorenin, can
occupy a recently cloned receptor called the prorenin receptor
(P)RR that binds both renin and prorenin [7]. The (P)RR can
signal via MAP-kinase pathways and serves to activate prore-
nin. Its more global function is currently being investigated;
however, the (P)RR has not been found to be implicated in
volume regulation. Ang I is inert, while Ang II signals through
two receptors: the AT1 and the AT2 receptors that have different
functions, AT1 displaying two different isoforms (AT1A and
AT1B), which have been characterized in mice [8]. Ang I and
Ang II can be cleaved to further products melding into a
septapeptide called Ang (1-7). The recently discovered
angiotensin-converting enzyme-2 (ACE2) is responsible for
this cleavage activity. Ang (1-7) can signal through a unique
receptor encoded by the Mas protooncogene, the Mas recep-
tor. The steroid hormone ALD, stimulated by Ang II, signals
through the mineralocorticoid receptor (MR).
In very general terms, the salt reabsorptive and vaso-
constrictor mechanisms are stimulated by Ang II and are
mediated by the AT1 receptor. The AT2 receptor has more
ameliorative and modulating effects. The primary salt
reabsorptive mechanisms are stimulated by ALD via the
MR. Ang (1-7) appears to have actions that are generally
opposite to those of Ang II so that its actions may also be
ameliorative. The complex actions of the RAAS on its
target organs and cellular messenger systems have been
reviewed [6, 9].
Evolution of the renin–angiotensin system
The evolution of the RAAS can be used to gain insights
about its molecules and components, for which some ques-
tions remain open: Do we know all components of the
system? Are they all similarly important? When did this
system emerge and why? Is the system conserved in diverse
animal species? Answering these questions is relevant to
complete our understanding of how the system functions in
humans, how it is involved in cardiovascular diseases, and
why pharmacological interference of the RAAS is effective
in their treatment [9, 10].
Today, genomic sequence data can be used to study
RAAS evolution; however, the RAAS has been studied with
comparative physiological techniques that also provided
evolutionary insights. Homer Smith, who dominated renal
physiology in the first half of the twentieth century, was
extremely interested in comparative physiology and renal
evolution [11]. He described the ureatelic phenotype of the
lungfish, which can survive in mud-caked enclaves for over
a decade without water. His activities culminated in a sem-
inal book, From Fish To Philosopher, published in 1953
[12]. In a prescient fashion that would have pleased Claude
Bernard, Smith describes the evolution of the milieu intér-
ieur regulation in vertebrates. Smith followed renal evolu-
tion with model organisms from the present and what he
could discern from fossil records. His notion was that organ-
isms evolved in “relatively” brackish water with electrolyte
contents similar to the extracellular environment of today.
Evolution offered challenges, such as return to the sea and
movement to fresh (electrolyte poor) water, to land, and
even to the air. Organisms were faced with the problem of
maintaining their internal environment and also excreting
the end products of protein metabolism. Smith was inter-
ested in the different solutions that species have evolved
for volume regulation and nitrogen excretion. Some
organisms have developed ancillary organs (gills for fish,
skin for amphibians, and rectal or orbital glands for
sharks, crocodiles, and birds). However, we humans are
largely stuck with “body-is-a-box.” Entry is via the mouth
and excretion occurs through the kidneys and to a minor
extent via the feces.
In 1977, Taylor pointed out that a renin-like material is
present in many vertebrate species [13]. He observed no
evidence of renin's presence in cartilage fish and concluded
that renin first appeared in bony fish, amphibians, and
subsequent vertebrates. Nishimura and Bailey published a
remarkable early paper on the intrarenal RAAS in various
vertebrates [14]. They pointed out that renin activity and
granulated epithelial JGA cells are present in bony fish,
dipnoans (lung fish), amphibians, birds, and mammals.
Nishimura, Bailey, and others observed that in fish, JGA
cells are distributed along small arteries and arterioles of the
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kidney. They also cited evidence that Ang II increases blood
pressure in bony fish and that reduced renal perfusion
increases plasma renin activity (PRA) in this family.
Nishimura and Bailey investigated the toadfish [14]. This
animal belongs to the Batrachoididae family that includes
members without glomeruli (like the seahorse). They per-
formed a remarkable study of blood pressure reduction in
the toadfish and reported the resultant effect on PRA. The
PRA assay measures the conversion of angiotensinogen to
Ang I and is not the same as measuring renin directly.
However, the responses were not different than we would
expect in mammals. Nishimura and Bailey also studied the
effects of captopril, an ACE inhibitor, and proved that the
effects involved Ang II generation. The investigators next
directed their attention to birds (skipping reptiles). They sub-
jected hens to hemorrhage. They found a pari-passu increase
in PRAwith decrease in blood volume and blood pressure in
the fowl. They next infused Ang II in the chickens and showed
a remarkable effect on blood pressure and sodium (as
chloride) excretion, implying RAAS regulation.
Liang et al. [15] were the first to identify renin genes in
two non-mammalian vertebrates, zebrafish (Danio rerio)
and pufferfish (Takifugu rubripes). RT-PCR results con-
firmed generation of the predicted zebrafish mRNA and its
expression in association with the opisthonephric kidney of
adult zebrafish. They then performed comparative in situ
hybridization analyses of wild type and developmental
mutants. Their findings indicated that renin expression was
first detected bilaterally in cells of the inter-renal primordia
at 24 h post-fertilization. The cells subsequently migrated to
lie adjacent to the glomerulus of the developing pronephric
kidney. The observation that the earliest renin-expressing
cells that arose during ontogeny of a teleost vertebrate are of
adrenocortical lineage raises an interesting hypothesis
Fig. 1 Scheme of the
components of the hormonal
RAAS. a Liver-produced
angiotensin (AGT) is cleaved
by renin from the kidney to
the decapeptide angiotensin I
(Ang I), which in turn is
converted to Ang II (largely in
the lung). The effector Ang II
directs the adrenal gland to
release aldosterone (ALD),
which directs the brain to
increase sympathetic tone,
drinking, and salt appetite and
also increases vasomotor tone.
ALD, sympathetic tone, and
Ang II act independently to
affect NaCl reabsorption in the
kidney. A reverse feedback
mechanism exists. b The
components involve a series of
proteins (substrates, enzymes,
and products) that can be
defined by genomic study and
followed across evolution.
(P)RR prorenin receptor,
ACE and ACE2 angiotensin
converting enzymes 1 and 2,
AT1 and AT2 angiotensin recep-
tors 1 and 2, Mas Mas receptor,
MR mineralocorticoid receptor.
In addition to this hormonal
RAAS, the system also acts
locally at the tissue level, e.g.,
brain, adrenal gland, and heart
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regarding the origin of renin-expressing cells in the meta-
nephric kidney of higher vertebrates. Expression of renin in
the adrenal gland of murine embryos indicates that this is
also first in ontogeny in mammals and further supports that
this renin expression is ancestral to renin's expression in the
kidney [16].
Salzet et al. [17] have reviewed RAAS elements in inver-
tebrates and vertebrates. Since genome sequences were not
available at the time of their report, their study could not rely
on genomic data, but instead included inferences from
immunoassays and immunohistochemistry. They recog-
nized the presence of ACE-like proteins in the fly and
renin-like enzymes in leeches. They extended their discus-
sion to certain vertebrate models. The authors pointed out
that snakes developed anatomical and functional adaptations
and interesting structural peculiarities that are found in their
autonomic, kallikrein-, renin–angiotensin-, and endothelin-
related systems.
The physiological evidence indicates that the RAAS was
established in bony fishes. Examining the lamprey could
help us establish the origin of the system more precisely
since these cyclostomes are the sister taxon of all living
jawed vertebrates, the gnathostomes. Brown et al. estab-
lished a radioimmunoassay to measure Ang II in lampreys
Fig. 2 Phylogeny of the
species whose sequences are
studied in this review. The
main groups displayed are the
chordates, which comprise all
species considered except
Drosophila and Caenorhabditis,
and display a notochord, at
least at some point during their
embryonic development.
Vertebrates are species
displaying vertebra and comprise
all considered chordate species,
with the exception of Ciona and
Amphioxus. Finally, the
tetrapods comprise all our
vertebrate species, with the
exception of fishes, either
cartilage fishes (elephant shark,
CallorhinchusMilii), bony fishes
(zebrafish, Danio rerio),
coelacants, or lungfishes
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[18]. They performed acute volume depletion by removing
40 % of the animal's blood volume. This maneuver doubled
Ang II concentrations. They then exposed the animals to a
decrease in salinity (758 to 605 mosm/kg H2O), which rapidly
decreased Ang II with a subsequent increase in Ang II. Inject-
ing saline solution intraperitoneally into fresh-water-
acclimated lampreys also decreased Ang II concentrations.
The results suggest that Ang II may play a role in volume
regulation of these primitive vertebrates. The data are consis-
tent with the idea that the Ang II peptide has been around for
500 million years. Missing from the authors' data are mass-
spectrometry-determined amino acid sequences of the pepti-
des. These results are fascinating; however, more precise
methodologies would be important to prove beyond any doubt
that the investigators indeed were dealing with Ang II [19].
DNA sequence analysis of an ancient system
To complement the available physiological evidence on the
evolution of the RAAS, we used the information available
from the gene and protein sequences in public databases
[20]. Complete genomes are especially useful since they allow
us to evaluate the presence of a given protein and also inform
us of its absence. Particularly, the latter state-of-affairs can be
very revealing [21]. We focused our analysis in the search for
sequence homologs of genes encoding nine of the human
proteins mentioned previously in 12 representative model
organisms (Fig. 2 and Table 1). The genomes of these organ-
isms, except the one of the elephant shark, Callorhinchus
milii, have been completely sequenced. We used the BLAST
algorithm [22] to search the NCBI protein database. Orthol-
ogy was verified with reciprocal searches. Finally, the sequen-
ces collected were aligned, and construction of phylogenetic
trees was used to verify that the sequences were orthologous
to the human gene.We note that although the function of some
proteins that we report has been experimentally verified, many
are merely predicted translation products from genes resulting
from genome sequencing projects awaiting verification.
Furthermore, sequencing of additional genomes could clearly
make this analysis more complete.
The main pattern of our findings agrees with physiolog-
ical evidence (Fig. 3). Most of the components emerge
concomitantly to appearance of the juxtaglomerular appara-
tus. For instance, the zebrafish, Danio rerio, our represen-
tative of bony fishes, constitutes the taxon with the most
Table 1 Homologs of nine human proteins of the renin–angiotensin–aldosterone system. Sequences are identified by GenPept identifiers
Empty cells are highlihgted in dark gray to remark that we did not find the corresponding ortholog in the indicated species. Cells shaded in light gray
indicate genes that are ancestral to multiple human genes
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primitive JGA [23] and already contains orthologs to eight
of the nine proteins considered. The exception is the oncogene
Mas, which seems to have evolved later in the tetrapod lineage.
We found Mas in the frog Xenopus tropicalis, our amphibian
representative. Orthologs of the nine genes could be found in all
tetrapod species analyzed, indicating the molecular stability of
the pathway. We could not find the renin protein in Gallus
gallus, the chicken, representing birds in our study. However,
clear homology to full human renin was found in genomic
shotgun sequences corresponding to chromosome 26 of Gallus
gallus. These sequences have not been yet assembled to the
current version of the Gallus gallus genome.
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Angiotensinogen, because of its central role in the sys-
tem, could be the best molecule to establish the time of
RAAS emergence. We found an angiotensinogen ortholog
in the shark Callorhinchus milii, confirming that the RAAS
was established with the appearance of gnathostomata, the
jawed fishes. Unfortunately, the shark genome is not yet
completely sequenced, and we could not find any other
sequences of the genes we tested.
We could not find an angiotensinogen ortholog in lampreys.
We note that some lamprey sequences are currently annotated
in GenBank as putative angiotensinogens (e.g., FM954978
from Lampetra fluviatilis [24]), but reciprocal sequence simi-
larity searches to the proteins from bony fish Danio rerio or
human suggest that they are orthologs of SERPIND1.
Angiotensinogen displays a serpin domain (Fig. 4a).
Serpins are known as protease inhibitors [25]. Ancestral
binding of angiotensinogen to proteases may have been a
prerequisite to cleavage of angiotensinogen by proteases
such as renin [26].
The fact that some of the genes analyzed existed prior to
the appearance of angiotensinogen can be used to trace the
ancestry of the system. However, the finding also indicates
the incompleteness of our functional understanding regard-
ing these genes. The best example of the latter conclusion
can be illustrated with the mysterious (P)RR, also known as
ATP6AP2. We observed (P)RR orthologs in all organisms
with complete genomes analyzed, including Drosophila
melanogaster, our insect representative, and the worm Cae-
norhabditis elegans. The sequence length was fairly con-
stant, suggesting a well-conserved domain organization.
ATP6AP2 presumably gained function with respect to the
binding of prorenin and renin, later in evolution [7]. Most
likely, the more ancestral function of this protein is related to
its association with vacuolar H(+)-ATPase, a complex that
regulates the pH of several intracellular compartments.
Whether or not these two seemingly unrelated functions
are interrelated remains to be determined [27].
Evidence of functions ancestral to the emergence of the
RAAS can also be proposed for ACE and ACE2. We found
orthologs of both proteins in Ciona intestinalis, the sea
squirt, which is our tunicate representative and in Bran-
chiostoma floridae, the amphioxus; both representing
primitive chordates. These two model organisms lack
most of the molecular and physiological components of
the system, including angiotensinogen. ACE and ACE2
are absent in Drosophila, which has homologous sequen-
ces sharing probable ancestry but that belong to a differ-
ent family, namely, the angiotensin converting enzyme
gene (ANCE) and angiotensin converting enzyme related
(ACER). Both of these enzymes are active endopepti-
dases during fly development but seem to lack a clear
function in adulthood [28].
ANCE is able to hydrolyze Ang I [29], whereas ACER
cannot perform this function [28]. This finding suggests that
the enzymatic activity for the processing of angiotensinogen
products existed prior to the appearance of angiotensinogen
itself. Angiotensinogen could possibly have emerged as an
adaptation to existing ACE metalloproteinases.
It is interesting to note that ACE activity seems to be related
to fertility and development in organisms ranging from insects
to mouse. ANCE has been suggested to play a role in the
peptide-processing enzyme in seminal fluid of Drosophila
[30]. In the mosquito Anopheles stephensi, ANCE may regu-
late embryogenesis when activated by blood meal [31], while
in freshfly Neobellieria bullata, several substrates or inhibi-
tors of ACE activity are present during development of ova-
ries, suggesting a role of ACE activity in the reproductive
system [32]. Besides, an isoform of ACE is only present in
germ cells of wild-type male mice [33], while male mice
deficient for germinal ACE show infertility [34].
The biological plasticity in repurposing the catalytic
domain of the ACE enzymes is further exemplified by the
fact that many bacteria contain an ACE protein that cleaves
Ang I to Ang II. This state-of-affairs was proven for the
Xanthomonas axonopodis pv. citri protein [35]. Interesting-
ly, we observed that the closest homologs of this bacterial
sequence in eukaryotic species are non-vertebrate chordate
orthologs of human ACE2, for example, Branchiostoma
floridae, GenPept identifier 260799397 (E value01e-168).
More significantly, our phylogenetic analysis clusters bac-
terial sequences with the ACE2 sequences of Ciona intesti-
nalis and Branchiostoma floridae (Fig. 5). Our observation
suggests that this bacterial family is the result of a horizontal
transfer event involving an ancestral ACE2 that happened in
an ancestor of Ciona intestinalis after the divergence of
tunicates from other chordates. The structure of the bacterial
phylogenetic tree suggests further events of horizontal
Fig. 3 Comparison of the RAAS in multiple species. a Left panel
(yellow) includes data from physiological studies: presence known or
supposed of RAAS in the central nervous system (CNS), juxtaglomer-
ular cells (JGCells), plasma renin activity (PRA), and angiotensin or
angiotensin-like activity known (AGT). Note that PRA does not mea-
sure renin, but rather the conversion of AGT to Ang I; renin is not the
only enzyme with this capability. Right panel (blue) shows sequence
data found by BLAST inquiry. Blanks indicate instances in which the
property could not be found. Question marks denote instances of
uncertain or contradictory data. b Model of the stepwise emergence
of the components of the RAAS based on their conservation across
several taxonomic divisions. Ciona intestinalis contains the two ACEs
and the prorenin receptor, but the many components missing show
evidence that these three proteins have functions ancestral to the
RAAS. B. floridae has an additional member, AncAT, an ancestral
version of the angiotensin receptors. After a large gap, our next closer
relatives whose complete genomes we know, the bony fishes, have a
human-like system, with two notable differences: a possible use of a
precursor of aldosterone and the absence of the Mas receptor. The
tetrapods (mammals, reptiles, amphibians, birds) have the complete
system, with the exception of renin, which could be missing in aves
(see main text)
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transfer involving this gene between bacteria. Besides their
enzymatic properties, the ACEs have other non-catalytic
functions [36]. Bacteria might exploit these other functions
as well.
Domain analysis of this family is interesting because the
ACE2 orthologs (including the bacterial ones) and Drosoph-
ila melanogaster ANCE and ACER possess only a single
600 amino-acid peptidase domain (peptidase M2 domain).
In contrast, ACE orthologs have two such domains ([37],
Figs. 4a and 5). The strong similarity between the N- and C-
terminal domains in one Ciona intestinalis and in one
Branchiostoma floridae sequence suggest that the proteins
of the ACE subfamily have undergone multiple independent
events of domain duplication like the one leading to the
vertebrate ACEs. In mice, the two domains have different
importance in the development of hypertension, as has been
shown by selective deletion of one of the two domains [38].
Finally, in mammals, we observed a further member of
this family containing a single catalytic domain, termed
ACE3. The function of ACE3 is unknown. The best char-
acterized member is the mouse ACE3, which is expressed
and produces a protein in sperm; however, gene deletion
does not render mice infertile [39]. Orthologs of ACE3 exist
in cow, dog, and rat, while the human counterpart is a
pseudogene with multiple base deletions, insertions, and
stop codons. Moreover, murine ACE3 lacks the residues
necessary for ACE catalytic activity [40]. ACE3 expression
could possibly regulate the expression of the parental
ACE gene, a mechanism of post-transcriptional gene
regulation that is known to exist for other pseudogenes
[41]. The position of the ACE3 gene in human and
mouse genomes downstream from ACE is consistent with
this view. Our sequence analysis indicates that ACE3 is
the result of an N-terminal domain duplication of ACE
(Fig. 5). We did not find orthologs of this gene outside
of mammals.
It is important to note that beside ACEs, other enzymes
that can cleave Ang I to Ang II [5] have been found, such as
chymase, a protein expressed in the mast cells of heart and
blood vessels [5], and cathepsin G, a secreted serine pepti-
dase of neutrophils and mast cells [42]. These proteins
appear to have evolved well after the establishment of the
RAAS.
The AT1 and AT2 receptors, also termed AGTR1 and
AGTR2, are also evolutionary products of gene duplication.
We identified an ancestral sequence of the two proteins in
Branchiostoma (AncAT, Fig. 3a; supplementary Figure 1).
We did not find any homologue in the most distant Ciona.
This finding suggests that this protein family emerged after
divergence of tunicates from primitive chordates. Again, the
functional relationship of this gene with Ang II must have
occurred later in evolution since angiotensinogen evolved
later (Fig. 3b). The Ang II receptor family may exhibit other
ancestral functions.
The MR probably predated angiotensinogen and renin.
The gene for the ancient MR protein might have been
duplicated in an ancestral organism before the emergence
of bony fishes [43, 44]. The primordial MR then evolved
(duplicated) to become a glucocorticoid receptor (GR). This
interpretation suggests that volume regulation is older than
stress-related responses. We traced MR easily to bony
fishes. Our cartilage fish sequence left us with a question
mark (Fig. 3a), and we will have to await additional
sequence information to be able to establish more precisely
the time of emergence of this receptor.
Finally, some inbred strains of laboratory mice (not the
widely used C57Bl/6) harbor a second renin gene (Ren-2)
[45]. Ren-2 is mainly expressed in the salivary gland of
males and is dramatically stimulated by aggression
(100,000-fold higher levels in saliva than plasma) [46].
Possibly, the aspartyl protease serves to injure a bitten
opponent or conceivably the protease serves a protective
function for wound healing after a fight by wound licking.
Interestingly, increasing angiotensinogen in the mouse by
infusion increases blood pressure substantially. The normal-
ly fairly low levels of angiotensinogen in the blood of mice
could be a response to the effectiveness of their salivary
renin. The fact that Ren-2 is strain-specific suggests that the
duplication of this gene is a relatively recent event. A
relative paucity of renin substrate in the mouse could have
favored this duplication [47]. Ren-2 actually provided the
first successful transgenic-rat model of hypertension, under-
scoring its amazing effectiveness in cleaving rat (cross
species) angiotensinogen [48].
Discussion
The important finding of our study is that most of the RAAS
component members began to appear with primitive chor-
dates and tunicates. All of the important components were
present with the development of bony fishes, with the
Fig. 4 Structural features of nine human proteins relevant to the
RAAS. a Domain organization of ACE, ACE2, renin, AGT, (P)RR,
and MR. T transmembrane alpha-helix (TM), S signal peptide (SP), P
pro-peptide (PP). Red box on angiotensinogen diagram: Ang I
sequence (AG). Red symbols indicate protein cleavage sites. b Solved
3D structures of these proteins or homologs (when indicated). ACE2:
peptidase domain (fragment 1-615, PDB:1R42); REN and AGT:
complex of renin (blue) and AGT (orange). Note the N-terminal of
AGT protruding into the renin molecule for processing (PDB:2X0B);
NRC32: steroid binding domain (blue; PDB:2AA2) and DNA binding
domain (green) with DNA (stick model) from 85 % identical rat
glucocorticoid receptor NRC31 (PDB:3G9P); AGTR1/AGTR2 are
30 % identical to the CXCR4 chemokine receptor whose structure is
shown (TM helices in green; PDB:3OE0). All protein structures are
represented using the PyMOL Molecular Graphics System software
(DeLano Scientific, Palo Alto, California)
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exception of the Mas receptor, which appears in amphibians.
We found solid evidence that angiotensinogen made its
appearance in cartilage fishes, but they are still a mystery
as this is the only sequence of the RAAS available so far in
sharks. This situation is unfortunate as this taxon is of
crucial importance in the understanding of the evolution of
volume regulation.
We included the (P)RR in our analysis, although the
protein has no known function in volume regulation. The
receptor has a component that serves as an important adapter
protein for a vacuolar ATPase, and for this reason, the
sequence is probably much older than the RAAS-related
function [7]. The function of this receptor is still not clear,
so the time point when its interaction with prorenin and
renin developed remains speculative.
We suggest a time-line for the evolution of the RAAS
components from Precambrian times to the present (Fig. 6).
Our scheme suggests that the emergence of the RAAS
resulted from the buildup of a peptidase core and subsequent
receptors working on an unknown substrate (cloud in
Fig. 3b). This core would have adapted to the processing
of angiotensinogen, was placed under the control of renin,
and finally completed its aim of volume regulation with
some adjustments in the downstream receptor elements.
These elements included the Mas oncogene and the MR.
The MR probably uses 11-deoxycorticosterone, the precur-
sor of ALD, in fishes, instead of ALD [49]. This entire
process would have occurred along 150 million years of
evolution in Paleozoic times followed by 400 million years
of relative stability. Our findings confirm and extend previ-
ous studies of the evolution of the RAAS, which point to its
emergence 400 million years ago, about the time cartilage
and bony fish diverged [13].
We are aware of shortcomings in our study. The verte-
brate classes are exceptionally diverse. Among them are
sharks that live in fresh water, bony fishes that spend time
in fresh water and then in sea water and vice-versa, sea-
going frogs and crocodiles, birds that fly over 5,000 km
water without any fresh water, and mammals that survive
without or within, fresh or sea, water. How do they do it?
We have merely scratched the surface. The transition from
genomic data to function, pathophysiology, and relevance
for man in health and disease is long and still incomplete.
We believe that it may be rewarding in the future. The
RAAS is a relatively well-studied system for these aspects.
We would be curious how Homer Smith would view these
genomic data. He would have probably demanded that the
lungfish be sequenced. We agree, and the more sequence
data we have, the more predictions we could make and the
more likely we will able to eventually identify the molecular
events that led to the interaction of relatively new ligands
(renin, angiotensinogen) to much older proteins that had
earlier different functions (ACE, AT1, AT2). However, the
data available provide ample evidence that new fields of
research, such as genomic, molecular evolution, and evolu-
tionary medicine, are emerging. This state-of-affairs has
been made possible by methodological advances in se-
quencing technology and internationally available, annotat-
ed databanks. With these new tools and knowledge, new
hypotheses can be formulated and tested computationally
and experimentally. The questions why specific genes and
metabolic pathways have been of advantage for survival and
reproduction during evolution can be answered by detailed
molecular analysis. A highly active RAAS offered an evo-
lutionary advantage because salt and volume homeostasis
were important for survival. Dramatic changes in environ-
ment when moving from salt water to fresh water (fish), then
to combined habitat water and land (amphibians) and to land
(reptiles, primates), had to be met by an efficient regulatory
system to maintain homeostasis. Such a condition was true
until Homo sapiens appeared 150,000 years ago [50] and
beyond. With the invention of salt for conservation in stored
food in advanced civilizations and excessive salt content in
Fig. 5 Evolution of the ACE family. a Phylogenetic tree of the
peptidase domains of selected eukaryotic and bacterial ACE homologs.
The numbers at the branches indicate number of bootstrapping tests
that resulted in the marked grouping: Values close to the total used
(100) indicate reliable branches. The labels indicate the subfamily, a
two letter abbreviation of the species name, GenPept identifier, and
amino acid range. Species abbreviations of eukaryotic species are dm
(Drosophila melanogaster), ci (Ciona intestinalis), bf (B. floridae), dr
(Danio rerio), mm (M. musculus), and hs (H. sapiens). ACE_xa
corresponds to the bacterial Xanthomonas axonopodis sequence; for
the other bacterial species, please refer to the database records. Dro-
sophila sequences contain a single domain (ANCE_dr, ; ACER_dm)
and constitute an outgroup indicating that they are ancestral to chordate
ACE1/ACE2. Multiple bacterial sequences (including the X. axonopo-
dis sequence) contain a single protease domain that groups with single
domain ACE2s and is not ancestral to both ACE1 and ACE2. This
suggests that the bacterial sequences are a result of horizontal transfer
from an ancestral chordate species. b Interpretation of the phylogenetic
tree. The ACE family originated before the divergence of chordates
from arthropods. Gene duplications (black dots) have expanded this
family, for example, leading to the existence of ACE1 and ACE2 in
chordates. Multiple events of domain duplication (red dots) have
happened in the ACE1 subfamily, an important one leading to the
vertebrate ACE1, which contains an N-terminal and a C-terminal
catalytic domain. ACE3 is a single domain ACE, which stems from
duplication of the mammalian C-terminal domain of the ACE1. This
sequence seems to have evolved into a pseudogene in humans (blue
line). Orthologs of vertebrate ACE2 are present in many bacterial
species. Their close homology to non-vertebrate ACE2s suggests that
they are the result of a single event of horizontal transfer from an ancestral
non-vertebrate species. The grouping in the phylogenetic tree of the
bacterial sequences analyzed here suggests that this initial event was
followed by further events of horizontal transfer between bacterial spe-
cies, indicating that bacterial ACEs have acquired a function that confers
an evolutionary advantage to the species bearing it. Multiple sequence
alignment was produced using the MUSCLE method [55] as imple-
mented at the EBI web server. The alignment was examined, and phylo-
genetic trees were generated using ClustalX Version 2.1 [56] excluding
positions with gaps and correcting for multiple substitutions
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industrialized nutrition, the RAAS is in constant overdrive,
causing salt and volume overload in the body with ensuing
hypertension, stroke, and cardiovascular diseases. There is
overwhelming evidence that salt is an important cause of
hypertension [51, 52]. The gap between the early function of
the RAAS and the completely different environmental chal-
lenges and nutrition today may be one of the evolutionary
reasons why hypertension, the number-one risk factor for
Fig. 6 Time-line of the emergence of the RAAS. Left geological eras
and a time-line (scale in millions of years). While most genes appeared
in the early Paleozoic, others might have emerged earlier in the Pre-
cambrian era and were adapted for their use as part of the RAAS. ACE
is one such example and might have evolved from an initial develop-
mental function to physiological actions on volume regulation in
vertebrates
506 J Mol Med (2012) 90:495–508
mortality worldwide, occurs in about half of the adult pop-
ulation nowadays [53].
In conclusion, by studying evolution, we can gain insight
into how our body works and eventually obtain clues on
how to deal with dysfunctions. We suggest that the sustain-
ing efforts in better understanding the RAAS will have soon
importance in the study of hypertension and other cardio-
vascular diseases. These would be important studies to
advance the concept of an evolutionary medicine [54].
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